Trials / Completed
CompletedNCT01890213
Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
A Pilot Study of Active Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study to evaluate the safety of a vaccine that consists of an alphavirus replicon (VRP) encoding the protein (CEA) that has been found to be associated with cancers such as colon cancer in patients that have stage III colon cancer. We will also evaluate the patient immune response to the vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AVX701 |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2017-06-01
- Completion
- 2019-07-01
- First posted
- 2013-07-01
- Last updated
- 2019-07-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01890213. Inclusion in this directory is not an endorsement.